Public releases 2016
Tuesday, January 17, 2017
Annual sales growth of 4.5%, at constant exchange rates
Friday, December 16, 2016
Virbac announces that it has received from the Food and drug administration (FDA) a communication confirming the lifting of the Warning Letter received in December 2015 for its St. Louis production site (Missouri, USA).
Thursday, October 13, 2016
Sales grow by 3.2% at the end of September at constant rates
Monday, September 19, 2016
Growth of half-year results
Monday, July 18, 2016
Sales growth by 3.6% at constant exchange rates in the first half
Wednesday, June 29, 2016
Virbac announces the appointment of Habib Ramdani as chief financial officer. Appointed to the executive board on June 23, 2016, Habib has overseen all financial activities of the Group since taking office on May 2, 2016, reporting directly to Éric Marée, chairman of the Virbac group executive board.